Pay in 4 interest-free payments of $5.62 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
It is crucial to understand the regulatory status of these options
In its Complete Response Letter on Tuesday, the FDA indicated that it was continuing to review safety data for Ocaliva from one of its confirmatory studies
se in alcuni stato evidenziato un ridotto rischio di aritmie e angina (ma non di insufficienza cardiaca e infarto), altri hanno evidenziato addirittura un possibile aumento del rischio di sviluppare malattie cardiache
Conserved molecular signatures of neurogenesis in the hippocampal subgranular zone of rodents and primates
US$ 29.02
US$ 23.15
US$ 20.11
US$ 26.85
US$ 21.21
US$ 26.35
